News

Chemical and Engineering News features UF College of Pharmacy researchers' efforts to find an opioid that doesn’t lead to addiction.

The title of the publication was "Oxytocin receptors are expressed by glutamatergic prefrontal cortical neurons that selectively modulate social recognition."

Drs. Lance McMahon and Jenny Wilkerson author a story for The Conversation about the rising popularity and the scientific interest in cannabidiol.

Khan was recognized in the postdoctoral fellow category of the poster competition.

Dr. Malany joins the UF College of Pharmacy department of pharmacodynamics. She was previously the principal investigator and director of translational biology at Sanford Burnham Prebys Medical Discovery Institute.

The grant will bolster research on Mitragyna speciosia, or kratom, and its potential to treat opioid misuse and physical dependence.

Join an emerging department with all its faculty federally funded and a dedication to training the next generation of scientists. Apply by December 1 to join our fall 2019 class.

A University of Florida College of Pharmacy professor found himself on the big screen in Time Square and national television ringing the NASDAQ opening bell in New York City.

Read about three ways UF Pharmacy is leading opioid research from the latest issue of GATORx.

Dr. Warren joins the Pharmacodynamics department as an assistant professor. He completed a postdoctoral fellowship at the National Institute on Drug Abuse before coming to UF. His drug addiction research endeavors to decode how drug memories are stored in the brain. Understanding how these memories are encoded may one day enable addiction treatment by strengthening or weakening specific drugs or memories.